Sexual & Reproductive · NeurobiologyPT-141
Bremelanotide
Melanocortin receptor agonist investigated in central signalling pathways.
EU Delivery: 2–4 Business Days
About this peptide
PT-141 (Bremelanotide) restores sexual desire and response by acting directly on the brain's melanocortin system — the true origin of arousal, not the blood vessels.
Unlike vascular agents, PT-141 works upstream in the nervous system, activating melanocortin-4 receptors to reignite genuine desire. It is effective for both men and women, whether the cause of low libido is physical, hormonal or psychological.
Users experience a return of spontaneous desire, stronger arousal and more satisfying intimacy — often after a single dose. It is the most complete peptide answer to sexual dysfunction available today.
Research profile
Acts on the brain rather than blood vessels.
Effective in male and female low libido.
Restores the psychological drive, not just the response.
Often effective within hours of a single dose.
Research areas
- Restores natural sexual desire
- Effective in both men and women
- Works when vascular agents fail
- Improves arousal and satisfaction
- Central, non-vascular mechanism
- Effect from a single on-demand dose
Specifications
- Class
- Melanocortin agonist
- Presentation
- 10 mg lyophilised vial
- Analytical
- Batch tested · HPLC verified
- Storage
- 2–8 °C, protect from light
Verified customer reviews
No reviews yet. Reviews come only from customers with a delivered order.
For research use only. Not intended for human or veterinary therapeutic use.
